• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

Overcoming Barriers to Access for Vitiligo Treatment

Experts in dermatological conditions provide insight on challenges patients and clinicians may face in accessing vitiligo medications, especially for newer therapies, and the future of vitiligo treatment.

Video Player is loading.
Current Time 0:00
Duration 6:20
Loaded: 0%
Stream Type LIVE
Remaining Time 6:20
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Panelists:

    George Han, MD, PhD

    Associate Professor, Donald and Barbara Zucker School of Medicine

    Vice President, Dermatologic Society of Greater New York

    Hofstra / Northwell

    North New Hyde Park, New York

    Susan C. Taylor, MD

    Bernett Johnson Endowed Professor of Dermatology

    Vice Chair for Diversity, Equity and Inclusion, Department of Dermatology Perelman School of Medicine, University of Pennsylvania

    Philadelphia, Pennsylvania

    Program Description:

    In this video series, experts in the management of dermatological conditions discuss vitiligo and aim to set clear and realistic expectations for patients living with this condition. In the conversation they explore how to facilitate and engage their patients in a constructive conversation about the use of topical therapy for this condition emphasizing the importance of appropriate follow-up and monitoring practices to ensure treatment success.

    Segment Description:

    Experts in dermatological conditions provide insight on challenges patients and clinicians may face in accessing vitiligo medications, especially for newer therapies, and the future of vitiligo treatment.

    © 2025 MJH Life Sciences

    All rights reserved.